Nice tamoxifen breast cancer prevention

Using the patient decision aids The NICE guideline recommends a shared approach to decision-making about chemoprevention. Jun 25, 2013 · Women with a high risk of developing breast cancer (a lifetime risk of 30% or more) should be offered tamoxifen or raloxifene for five years, NICE recommends

2024-03-29
    Losartan trade name
  1. 3
  2. breast cancer for various reasons
  3. Tamoxifen is a SERM
  4. Tamoxifen is a pill taken every day for 5-10 years
  5. 1998; 90: 1371-1388
  6. Results